Skip to main content
LCTX logo

LCTX · Lineage Cell Therapeutics, Inc.

$1.14 +0.04 (+3.64%) At close · Jul 21
Market Cap
$275.47M
Shares
249.30M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

The Jun 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out.
Holders: 129
Total Value: $174,589,099
Total Shares: 111,658,195
Showing 1–100 of 132 holdings by value · page 1 of 2

Institutional Ownership Trend

26 quarters

Holder Concentration

Across 131 13F filers
Top Holder
44.3%
Jun 2023 → Mar 2026 · range 38.9% – 56.2%
of institutional value
Top 5
67.5%
Jun 2023 → Mar 2026 · range 67.5% – 80.7%
of institutional value
Top 10
83.0%
Jun 2023 → Mar 2026 · range 83.0% – 91.1%
of institutional value
HHI
2,168
Jun 2023 → Mar 2026 · range 1,817 – 3,361
Moderately concentrated
Showing 100 of 132
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 876343 CUSIP 53566P109 13F (30d) 9 filings 9 filers Visit website Investor relations